Dr. Arnab Pal
Designation : Professor
Department : BIOCHEMISTRY
pal.arnab@pgimer.edu.in

 
 
 :: Educational Qualification
  Graduation :   MBBS from RGKar MC Calcutta University in year 1998
  Post Graduation :   MD(Biochemistry) from AIIMS New Delhi in year 2005
  Other Qualification.(1)      :   PhD from AIIMS New Delhi in year 2009
  Other Qualification.(2)      :   MAMS from National Academy of Medical Sciences in year 2016
     
 :: Area of Interest
       Area Of Interest       :

Our group works on development of newer biomarkers for cancers.


Areas of Interest:

  • We are trying to develop a tumor marker for early diagnosis of Head Neck Squamous Cell Carcinoma (HNSCC) using proteomics  based techniques. We have already identified a panel of salivary proteins for early diagnosis of Oral Cancer.
  • Using Radiogenomics for prediction of radiation toxicity/treatment response is another field of our work.
  • Diagnostics based on transcriptomics of Circulating Tumour Cells (CTCs)- identification, enumeration and gene expression.


For more details please visit our lab website:https://www.lab320pgi.com
     
 :: Research & Projects
      Extramural Projects       :

S.

No.

Title of project

Funded by

Amount (Rs in lakh)

Date of commencement

Date

of Completion

1.

Cripto 1: Evaluation as a potential tumor marker in Oral Squamous Cell Carcinoma

DBT

33,30,800

June 2013

Dec 2016

2.

Identification and validation of potential salivary biomarker(s) for Oral Squamous Cell Carcinoma (OSCC) by analysis of salivary proteome.

DST- SERB

35,98,800

March 2017

Feb 2020

3.

Identification of potential biomarker(s) for tobacco-induced Oral Squamous Cell Carcinoma: a proteomic based approach.

PGIMER

5,00,000

Feb 2016

Feb 2018

4.

Evaluation of Kallikrein 1

(KLK1), Prosaposin A (PSAP) and S100-A7 as potential biomarker in Oral Squamous Cell Carcinoma (OSCC): A pilot study.

PGIMER

5,00,000

March 2018

Mar 2020

5

Development of personalized radiation treatment regime using Radio-genomics based radiation toxicity prediction model in Head Neck Squamous Cell Carcinoma (HNSCC).

ICMR

52 Lakh

Sept2019

Sept 2022

6

Evaluation of Differential expression Genes involved in invasion/metastasis                   in Circulating Tumor Cells (CTCs) in Oral Squamous Cell Carcinoma (OSCC): A Pilot

Study.

PGIMER

5,00,000

April 2019

April 2021

7

Exploration of role of cornulin as potential therapeutic agent in Head and Neck Squamous Cell Carcinoma (HNSCC).

ICMR

27,21,604

March 2021

Feb 2024
      Departmental / P.G.I.
      Projects      		 :
      Research In
      Progress      		 :

S. No

Title

Cost

Agency

 

Status

 

1.       

Gene Expression Profile of Circulating Tumor Cells associated with Loco-regional Nodal Metastasis in Head and Neck Squamous Cell Carcinoma: Relation to Clinical Implications.

 3,641,500

 ICMR

Technically Approved in 2022

2.       

Development of Gene Expression Panel of Circulating Tumour Cells (CTCs) in Head and Neck Squamous Cell Carcinoma (HNSCC): Diagnostic and Clinical Implications.

3,593,000

ICMR

Technically Approved

2022

3.       

Validation of Circulating Tumour Cells (CTCs) based diagnostics in Prognosticating Oral Squamous Cell Carcinoma: An Approach to Personalized Cancer Management.

1.2 Crores

ICMR- ICRC Task Force

Technically Approved

2022
      Area Of
      Specialization      		 :
Tumour biomarkers

Liquid Biopsy and Circulating Tumour Cells (CTC)

Clinical Biochemistry
      Future Plans       :

Tumour biology 

  • We work in development of newer biomarkers for cancers. We are trying to develop a tumour marker for early diagnosis and/prognosis of Oral Squamous Cell Cancers (OSCC) and have identified a novel serum-based tumour marker Cripto1 for OSCC by candidate gene approach. We are also looking into other plausible markers for OSCC in both serum and saliva by Mass Spectrometry based proteomic screening approach.  

  • We are also working in the analysis of Circulatory Tumour Cells (CTCs) Biology to identify differentially regulated pathways in CTCs required for metastasis.

  • We are working in the field of personalized radio genomics in a way to find new tools for predicting radiation reactions in Head & Neck Cancers. 

 

Molecular dermatology 

  • The other area of interest is to identify genetic factors determining the severity and progression of Acne and identifying role of different acne modulation drugs. 
      Awards & Honours       :
Member of National Academy of Medical Sciences
      Member Of Professional
      Bodies      		 :
  • Life member of Association of Clinical Biochemistsof India(ACBI)
  • Life Member of Association of Medical Biochemists of India (AMBI)
  • Life Member of Indian Association for Cancer Research (IACR)
  • Member of American Association for Cancer Research (AACR)
  • Member of European Association for Cancer Research (EACR)
     
 :: Publications(In Vancouver Style)
INDEXED

Original Articles:
  •  Mehndiratta M, Palanichamy JK,Ramalingam P, Pal A, Das P, Sinha S, Chattopadhyay P. Fluorescence acquisitionduring hybridization phase in quantitative real-time PCR improves specificity and signal-to-noise ratio. Biotechniques. 2008 Dec; 45(6):625-6, 628, 630 passim.6 (Impact Factor 2.9)
  •  Pal A,Srivastava T, SharmaMK, Mehndiratta M, Das P, Sinha S, Chattopadhyay P. Aberrantmethylation and associated transcriptional mobilization of Alu elementscontributes to genomic instability in hypoxia. J Cell Mol Med. 2010Nov;14(11):2646-54. (Impact Factor 5.2)
  •  Mehndiratta M, Palanichamy JK, Pal A, Bhagat M, Singh A, Sinha S, Chattopadhyay P. CpG Hypermethylationof the C-myc Promoter by dsRNA Results in Growth Suppression. Mol Pharm. 2011 Dec 5;8(6):2302-9. doi: 10.1021/mp200177z. Epub 2011 Sep 19. (ImpactFactor 4.4)
  •  Roy J, Mitra JK, Pal A.Magnesium sulphate versus phenytoin in eclampsia - Maternal and foetal outcome - A comparative study.Australas Med J. 2013 Sep 30;6(9):483-95. (Impact Factor NA)
  • RAthar, Y Khonglah, V Raphael, A Pal, K G Lynrah.Clinico-Hematologic And Biochemical Profile Of Dimorphic AnemiaWith Bone Marrow Study. DOI: 10.5580/IJLM.16197.
  • Bela Goyal, Sudip K Datta, Altaf AMir, Saidaiah Ikkurthi, Rajendra Prasad, Arnab Pal*. Increasing glucoseconcentrations interfere with estimation of electrolytes by indirect ionselective electrode method. Indian J Clin Biochem. 2016 Apr;31(2):224-230.
  • Altaf A Mir, Bela Goyal , SudipKumar Datta , Saidaiah Ikkurthia, Arnab Pal*. Comparison of calculated andmeasured calcium levels (Total and Ionized) at different albuminconcentrations. J Lab Physicians. 2016 Jul-Dec;8(2):71-6. doi: 10.4103/0974-2727.180785.
  • Sk. Md. Amanur Rahaman, DipankarDe, Sanjeev Handa, Arnab Pal, Naresh Sachdeva, Tulika Ghosh, Parul Kamboj.Association of insulin-like growth factor (IGF)-1 gene polymorphisms withplasma levels of IGF-1 and acne severity. J Am Acad Dermatol. 2016Oct;75(4):768-773. doi: 10.1016/j.jaad.2016.05.019. Epub 2016 Jul 27. (ImpactFactor 7.002)
  •  Mohit Nagpal, Dipankar De, Sanjeev Handa, Arnab Pal, Naresh Sachdeva. InsulinResistance and Metabolic Syndrome in Young Men With Acne. JAMA Dermatol.2016 Apr;152(4):399-404.doi: 10.1001/jamadermatol.2015.4499. (Impact Factor 5.8)
  •  Thakur JS, Jeet G, Pal A,Singh S, Singh A, Deepti SS, Lal M, Gupta S, Prasad R, Jain S, Saran R. Profileof Risk Factors for Non-Communicable Diseases in Punjab, Northern India:Results of a State-Wide STEPSSurvey. PLoS One. 2016 Jul 7;11(7): e0157705. (Impact Factor 2.8)
  •  Tripathy JP, Thakur JS, Jeet G,Chawla S, Jain S, Pal A, Prasad R. Burden and risk factors of dyslipidemia-results from a STEPS survey in Punjab India.Diabetes Metab Syndr. 2016 Aug 23. pii: S1871-4021(16)30173-4. doi:10.1016/j.dsx.2016.08.015. [Epub ahead of print] (Impact Factor NA).
  • Tripathy JP, Thakur JS, Jeet G,Chawla S, Jain S, Pal A, Prasad R, Saran R. Prevalence and risk factorsof diabetes in a large community-based study in NorthIndia: results from a STEPS survey in Punjab, India. DiabetolMetab Syndr. 2017 Jan 23;9:8. doi: 10.1186/s13098-017- 02073. eCollection 2017.(Impact factor 2.347).
  • Rahaman AS, De D, Handa S, Pal A,Sachdeva N, Ghosh T, Kamboj P. What is normal insulin-like growth factor-1level? J Am Acad Dermatol. 2017 Jun;76(6):e225. doi:10.1016/j.jaad.2017.02.037.(Impact Factor 7.002).
  • S. Kumar, D. De, S. Handa, R. K.Ratho, S. Bhandari, A. Pal, P. Kamboj and S. Sarkar. Identification of factorsassociated with treatment refractoriness of oral lesions in pemphigus vulgaris.doi: 10.1111/bjd.15658. (Impact Factor 4.7).
  • Dhivya S, Singh SK, Pal A, Kakkar N and Prasad R. Insinuations of p53 and MDM2 in RenalCell Carcinoma progression. Ann Mutagen. 2017; 1(1): 1005. (Impact Factor NA).
  • Saidaiah Ikkurthi, SrinivasBalachander, Bela Goyal, Altaf Ahmad Mir, Subho Chakrabarti, Arnab Pal*. A comparative evaluation of lithium estimation for samples collected in different tubesand its stability on storage. doi:10.4103/JLP.JLP_78_17. (Impact Factor NA).
  • Ajay Kumar, Vinod Kumar, VidyaRattan, Vivekananda Jha, Arnab Pal, Shalmoli Bhattacharyya. Hepatogenic potential of stem cells derivedfrom bone marrow& dental tissue- Is secretome a player?Sci Rep. (UnderCommunication no SREP-17-22384A). (Impact Factor4.26).
  • S Najmy, A Duseja, A Pal, S Sachdev, RR Sharma, NMarwah, Y Chawla. Redefining the normal values of serum aminotransferases inhealthy Indian males. Journal of Clinical and Experimental Hepatology. (In Press).
  • Kumari N, Kumar A, Thapa BR, ModiM, Pal A,Prasad R. Characterization of mutation spectrum and identification of novelmutations in ATP7B gene from a cohort of Wilson disease patients: Functionaland therapeutic implications. Hum Mutat. 2018 Aug 18. doi:10.1002/humu.23614. [Epub ahead of print] (ImpactFactor 5.3)
  • Bhat FA, Advani J, Khan AA, Mohan S, Pal A, Gowda H, Chakrabarti P, Keshava PrasadTS, Chatterjee A. A network map of thrombopoietin signaling. J Cell Commun Signal. 2018 Jul24. doi:10.1007/s12079-018-0480-4. [Epub ahead of print] (Impact factor 2.5)
  • Garg G, Patil A, Singh J, KaushikN, Praksah A, Pal A, Chakrabarti A. Pharmacological evaluation of Convolvuluspluricaulis as hypolipidaemic agent in Triton WR-1339-induced hyperlipidaemiain rats. J Pharm Pharmacol. 2018 Sep 4. doi: 10.1111/jphp.13004. [Epub ahead ofprint] (Impact Factor 2.3)
  • Vishalakshi N, Remya Raja, AneeshaRadhakrishnan, Ankit P Jain, Keshava K Datta,Vinuth N Puttamallesh, Hitendra S Solanki, Sandip Chavan, Arun Patil,Santosh Renuse, Anu Jain, Don Mathew, Reetu Thakur, Rafael Guerrero-Preston,Bipin Nair, Samapika Routray, Neeta Mohanty, KB Linge Gowda, Ritesh Jadav,Sushmita Ghosal, Rekha V Kumar, Chaluvarayaswamy Ramesha, Vijay C Raghu,Premendu Prakash Mathur, TS Keshava Prasad, Joseph A Califano, David Sidransky,ArnabPal, Mandakulutur S Ganesh, Jay GopalRay, Akhilesh Pandey, Harsha Gowda, Aditi Chatterjee. Testican 1 (SPOCK1) andprotein tyrosine phosphatase, receptor type S (PTPRS) show significant increasein saliva of tobacco users with oral cancer. Translational Research in OralOncology. Volume 3: 1–11. Doi:10.1177/2057178X18800534.
  • Anu Jain, Sumanth K Malluputtu,Reetu Thakur, Sushmita Ghoshal, Arnab Pal*. Cripto1, a potential biomarkerfor oral squamous cell carcinoma. Oral Oncol. 2018 Dec 17. pii: S1368-8375(18)30410-X. doi: 10.1016/j.oraloncology.2018.11.001. (Impact Factor 4.6)
  • Ajay Duseja, Shaneez Najmy, SuchetSachdev, Arnab Pal, Rati Ram Sharma, Neelam Marwah, Yogesh Chawla. Highprevalence of nonalcoholic fatty liver disease (NAFLD) among healthymale blood donorsof urban India.J of Gastroenterology and Hepatology Open. (JGHOPEN-2018-081, Accepted for Publication) (Impactfactor NA).
  • Manjunath Havalappa Dodamani,Valliappan Muthu, Reetu Thakur, ArnabPal, Inderpaul Singh Sehgal, Sahajal Dhooria, Ashutosh N. Aggarwal, MandeepGarg, Arunaloke Chakrabarti, Ritesh Agarwal. A randomised trial of vitamin D inacute‐stage allergic bronchopulmonaryaspergillosis complicating asthma. Mycoses.2019; 62: 320– 327.https://doi.org/10.1111/myc.12879
  • Handa, S, Khullar, G, Pal, A, Kamboj, P, De, D. Filaggringene mutations in hand eczema patients  in  the  Indian subcontinent: A prospective case‐control  study.  Contact  Dermatitis. 2019; 80: 359– 364. https://doi.org/10.1111/cod.13233.
  • Sharma, A, De, R, Javed, S, Srinivasan, R, Pal, A, Bhattacharyya, S. Sonic hedgehogpathway activation regulates cervicalcancer stem cell characteristics duringepithelial to mesenchymal transition. J Cell Physiol.2019; 234: 15726– 15741. https://doi.org/10.1002/jcp.28231
  •  Jarnail Singh Thakur, GursimerJeet, Ria Nangia, Divya Singh, Sandeep Grover, Tanica Lyngdoh, Arnab Pal,Ramesh Verma, RamnikaAggarwal, Mohd Haroon Khan, Rajiv Saran,Sanjay Jain, KL Gupta, Vivek Kumar. Non-communicable diseases risk factors and their determinants: A cross-sectional state-wide STEPS survey, Haryana,North India. PLOS ONE 14(11): e0208872.https://doi.org/10.1371/journal.pone.0208872
  • Gupta, A., Mathew, D., Ghoshal, S. Pal, A*. XRCC1 (rs25487) polymorphism is associated with severe oralmucositis and poor treatment response after radiotherapy for oropharyngealcarcinoma. Oral Cancer 3, 37–47 (2019).https://doi.org/10.1007/s41548-019-00021-x.
  • Anu Jain, Sumanth Kumar Mallupattu,Reetu Thakur, Satyawati Mohindra, Amanjit Bal, Ashim Das, Sushmita Ghoshal& Arnab Pal*. Role of OncofetalProtein CR-1 as a Potential Tumor Marker for Oral Squamous Cell Carcinoma. IndJ Clin Biochem (2020). https://doi.org/10.1007/s12291-020-00898-2.
  •  Anu Jain, Chinmaya NarayanaKotimoole, Sushmita Ghoshal, Jaimanti Bakshi, Aditi Chatterjee, ThottethodiSubrahmanya Keshav Prasad, Arnab Pal*.Development of a potential salivary biomarker panel for Oral Squamous CellCarcinoma. MedRxiv 2020.06.08.20125054; doi:https://doi.org/10.1101/2020.06.08.20125054.
  • Dalai R, Dutta S, Pal A, Sundaram V, Jayashree M. IsLumbar Puncture Avoidable in Low- Risk Neonates with Suspected Sepsis? Am JPerinatol. 2020 Jul 21. doi: 10.1055/s-0040- 1714397. Epub ahead of print.PMID: 32693413. (IF 1.47 )
  • Oshan Shrestha, Alka Rani Khadwal,Manphool Singhal, Amita Trehan, Deepak Bansal, Richa Jain, Arnab Pal, Jasbir Kaur Hira, Sanjeev Chhabra, Pankaj Malhotra,Reena Das, Prashant Sharma high frequency of Gilbert syndrome (UGT1A1*28/*28) and associatedhyperbilirubinemia but not cholelithiasis in adolescent and adult north Indianpatients with transfusion-dependent β-thalassemia. Ann Hematol 99, 2019–2026(2020). (IF 2.9).
  • Chauhan, A., Kaur, R., Ghoshal, S. Pal A* Exploration of CirculatingTumour Cell (CTC) Biology: A Paradigm Shift in Liquid Biopsy. Ind J ClinBiochem (2020). https://doi.org/10.1007/s12291-020-00923-4.
  • Nayak S, Bawa M, Kanojia RP, Pal A, Jain A, Samujh R. TIMP-2 as anoninvasive urinary marker for predicting neurogenic bladder in patients underfollow-up for spina bifida. Neurourol Urodyn. 2021 Jan;40(1):168-175. doi:10.1002/nau.24528. Epub 2020 Oct 12. PMID: 33045111.
  • Chauhan A, Ghoshal S, Pal A*. Increased susceptibility ofSARS-CoV2 infection on oral cancer patients; cause and effects: An hypothesis.Med Hypotheses. 2020 Nov;144:109987. doi: 10.1016/j.mehy.2020.109987. Epub 2020Jun 9. PMID: 32562913; PMCID: PMC7282763.
  • Jain A, Ghoshal S, Pal A*. Letter to editor "The Roleof Nodal and Cripto-1 in Human Oral Squamous Cell Carcinoma". Oral Dis.2020 Nov 20. doi: 10.1111/odi.13730. Epub ahead of print. PMID: 33215782.
  • Kaur R, Chauhan A, Pal A*. HIF-1αcontributing to COVID-19infections and poor prognosisin cancer patients – A hypothesis. Indian Journal of Biochemistry &Biophysics 57(6):670- 675.
  • Bragg-Gresham J, Thakur JS, Jeet G,Jain S, Pal A, Prasad R, PennathurS, Saran R. Population-based comparison of chronic kidney disease prevalenceand risk factors among adults living in the Punjab, Northern India and the USA (2013-2015). BMJ Open. 2020 Dec13;10(12):e040444. doi: 10.1136/bmjopen-2020-040444. PMID: 33318117;PMCID: PMC7737106.
  • Gupta N, Bishnoi A, Mathew D, Arora A, Handa S, Kaur J, De D, Pal A*. Hypertrophic post- acne scarring is associated with a single nucleotidepolymorphism (rs243865) in the matrix metalloproteinase-2 gene. J DtschDermatol Ges. 2020 Dec;18(12):1426-1435. doi: 10.1111/ddg.14338. PMID: 33373134.
  • Sehgal IS, Dhooria S, Prasad KT,Muthu V, Aggarwal AN, Rawat A, Pal A,Bal A, Garg M, Chakrabarti A, Agarwal R. Sensitization to A fumigatus insubjects with non-cystic fibrosis bronchiectasis. Mycoses. 2020 Dec 17. doi:10.1111/myc.13229. Epub ahead of print. PMID:33332671.
  • Jain A, Kotimoole CN, Ghoshal S, Bakshi J, Chatterjee A, Prasad TSK, Pal A*. Identification of potential salivarybiomarker panels for oral squamous cell carcinoma. Sci Rep. 2021 Feb9;11(1):3365. doi: 10.1038/s41598-021-82635-0. PMID: 33564003; PMCID: PMC7873065.
  • Nayak S, Bawa M, Kanojia RP, PalA*, Jain A, Samujh R. TIMP-2 as a noninvasive urinary marker for predictingneurogenic bladder in patients under follow-up for spina bifida. NeurourolUrodyn. 2021 Jan;40(1):168-175. doi: 10.1002/nau.24528. Epub 2020 Oct 12. PMID:33045111.
  •  Mohanty V, Subbannayya Y, Patil S,Abdulla R, Ganesh MS, Pal A, Ray JG, Sidransky D, Gowda H, Prasad TSK,Chatterjee A. Molecular alterations in oral cancer between tobacco chewers andsmokers using serum proteomics. Cancer Biomark. 2021;31(4):361-373. doi:10.3233/CBM-203077. PMID: 34024816.
  • Bhat FA, Mohan SV, Patil S, AdvaniJ, Bhat MY, Patel K, Mangalaparthi KK, Datta KK, Routray S, Mohanty N, Nair B,Mandakulutur SG, Pal A, Sidransky D, Ray JG, Gowda H, Chatterjee A.Proteomic Alterations Associated with Oral Cancer Patients with Tobacco UsingHabits. OMICS. 2021 Apr;25(4):255-268. doi: 10.1089/omi.2021.0001. Epub 2021Mar 31. PMID: 33794113.
  • Gupta A, Mathew D, Bhat SA, GhoshalS, Pal A*. Genetic Variants of DNA Repair Genes as Predictors ofRadiation-Induced Subcutaneous Fibrosis in Oropharyngeal Carcinoma. FrontOncol. 2021 May 17;11:652049. doi: 10.3389/fonc.2021.652049. PMID: 34079756;PMCID: PMC8165303.
  • Otaal PS, Shah A, Batta A, Sood A, PalA*. Clinical and Angiographic Prophesy of Hemodynamic Status in Patientswith Acute Anterior Wall ST-Segment-Elevation Myocardial Infarction and TotallyOccluded Left Anterior Descending Artery. Integr Blood Press Control. 2021 Jun18;14:89-97. doi: 10.2147/IBPC.S315050. PMID: 34168494; PMCID: PMC8219224.
  • Kamboj P, Bishnoi A, Handa S, DuttaP, Nahar Saikia U, Pal A, De D. Effects of metformin on experimentallyinduced acne on rabbit ear. Exp Dermatol. 2021 Jul;30(7):966-972. doi:10.1111/exd.14347. Epub 2021 Apr 13. PMID: 33847400.
  • Sharma A, Kaur H, De R, SrinivasanR, Pal A, Bhattacharyya S. Knockdown of E-cadherin induces cancerstem-cell-like phenotype and drug resistance in cervical cancer cells. BiochemCell Biol. 2021 Oct;99(5):587-595. doi: 10.1139/bcb-2020-0592. Epub 2021 Mar 6.PMID: 33677985.
  • Chauhan A, Kaur R, Chakrbarti P, PalA*. "Silent Hypoxemia" Leads to Vicious Cycle of Infection,Coagulopathy and Cytokine Storm in COVID-19: Can Prophylactic Oxygen TherapyPrevent It? Indian J Clin Biochem. 2021 Oct;36(4):468-472. doi:10.1007/s12291-021-00967-0. Epub 2021 Mar 15. Erratum in: Indian J ClinBiochem. 2021 Apr 29;:1. PMID: 33746377; PMCID: PMC7958103.
  • Sehgal IS, Basumatary NM, DhooriaS, Prasad KT, Muthu V, Aggarwal AN, Pal A,Desai M, Chaudhry D, Supe PD, Kurmi P, Choudhuri R, Shah C, Agarwal R. ARandomized Trial of Mycobacterium w in Severe Presumed Gram-Negative Sepsis.Chest. 2021 Oct;160(4):1282-1291. doi: 10.1016/j.chest.2021.03.062. Epub 2021May 7. PMID: 33852919.
  • Kaur R, Chauhan A, Bhat SA,Chatterjee D, Ghoshal S, Pal A*. Gene of the month: Cornulin. J ClinPathol. 2021 Dec 30:jclinpath-2021-208011. doi: 10.1136/jclinpath-2021-208011.Epub ahead of print. PMID: 34969781.
  • Chauhan A, Kaur R, Ghoshal S,Chatterjee D, Pal A*. Potential prognostic and predictive role ofbaseline circulating tumor cells in head and neck squamous cell carcinoma. OralOncol. 2022 Jan;124:105636. doi: 10.1016/j.oraloncology.2021.105636. Epub 2021Nov 27. PMID: 34847451.
  • Bhat SA, Kaur R, Chauhan A, Pal A*.The microbiome and precision oncology: an emerging paradigm in anticancertherapy. Crit Rev Microbiol. 2022 Feb 15:1-14. doi:10.1080/1040841X.2022.2035313. Epub ahead of print. PMID: 35164642.
  • Boora GS, Chauhan A,Kaur R, Kaur H, Chandel J, Bhat SA, Ghoshal S, Pal A*. Genomicinstability detected from the saliva of Head and Neck Squamous Cell Carcinomapatients: Association with clinical implications. Arch Oral Biol. 2022 May; 137:105395.doi: 10.1016/j.archoralbio.2022.105395. Epub 2022 Mar 14. PMID: 35299001.

Case reports:

  • Sinha A, Pal A*, Lynrah KG. Graves’disease with non-functioning parathyroid adenoma: an uncommon association ofcommon diseases. Journal of Case Reports.2014; 4: 25357(Impact Factor NA)

 

Short reports/Abstracts:

  • Pal*,A M Mondal, M Mehndiratta, S Sinha & P Chattopadhyay. Hypoxia Causes GlobalDemethylation with Patchy Hypermethylation of CpG Islands of Repeat DNAElements in U87MG Human GlioblastomaMultiforme Cell Line. Indian J Med Res 121(Supplement), February 2005. p80.(Impact Factor 1.4)
  • S.Sen, A. Singh, A. Pal, C. Sharma, R. Kar, and N. Singh.Anti-cancer gene expression profile of curcumin identifies new therapeutic targetsin squamous cell lung carcinomain vitro. Journal of Clinical Oncology, 2007 Vol 25, No 18S (June 20 Supplement), 2007: 18203. (ImpactFactor 18.4)
  • S. Sen, C. Sharma, A.Pal,R. Kar, N. Singh. Multiple anticancer targets of chemopreventive curcumin insquamous cell carcinoma in vitro. European J Cancer, Vol 6, No 3, March 2008.(Impact Factor 5.4)
  • Sen S, Sharma C, Pal A, Kar R, Chattopadhyay P and SinghN. Antioxidant activityof curcumin facilitates itscancer chemotherapeutic potential in squamous cell lung carcinoma in vitro.Annals of Oncology, 2008; 19(Supple 8): 54-55. (Impact Factor 4.9)
  • Arnab Pal*,Dr Rashna Dass, Dr Chandan K Nath, Dr Nayan Deka, Dr Saurabh Gohain Duwarah, DrHimesh Barman. Abnormal Liver Function Test in Scrub Typhus in Pediatric Age Group. Indian Journal ofClinical Biochemistry. Vol25 Supplement 2010;78. (Impact Factor NA)
  • Chandan Kumar Nath, Arnab Pal*,Steven L Sailo. Chemical Analysis of Renal Stone of Patients VisitingNorth Eastern Indira Gandhi RegionalInstitute of Health& Medical Sciences, Shillong. Indian Journal ofClinical Biochemistry. Vol25 Supplement 2010;75-76. (Impact Factor NA)
  • Arnab Pal*, Anu Jain,Reetu Thakur, Sushmita Ghoshal, Sumanth M, Satyawati Mohindra. Cripto 1: A tumormarker for Oral Cancer. Ind J Clin Biochem. Volume29, Issue 1 supplement,pp 1-152, Dec 2014(Impact Factor NA)
  • A Jain, A. Pal*, R. Thakur, S. Ghoshal,M. Sumanth Kumar, S. Mohindra. CRIPTO -1: A NOVEL TUMOR MARKER FOR ORAL SQUMOUSCELL CARCINOMA (OSCC) Clinical Chemistry and Laboratory Medicine (CCLM). Volume53, Issue s1, Pages s98–s125, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621,DOI: 10.1515/cclm-2015-5002, May 2015. (Impact Factor 2.9)
  • Harshal Surendra Mandavdhare, UshaDutta, Uma Nahar, Lileshwar Kaman, Shalmoli Bhattacharya, Arnab Pal, AnuSharma, Neha Thakur,Surinder Singh Rana,Deepak K Bhasin. Prevalence and risk factors ofpreneoplastic lesions in the gallbladder mucosa among patients with symptomaticgallstones. Journal of Gastroenterology and Hepatology 31, 235-235.
  • U Dutta, U Nahar, HB Reddy, LKaman, S Bhattacharya, A Pal, R Kapoor. Tu1535-Gall BladderStasis in Patients with Gallstones Promotes Preneoplastic Lesions of GallBladder: Prospective Study. Gastroenterology 154 (6), S-955.
  • Shalmoli Bhattacharyya, AnukaSharma, Arnab Pal, Radhika Srinivasan. Knockdown of E- cadherin gene in cervical cancer cells: An in vitro model for cancer stem cellphenotype? Mol Cancer Ther 2019;18(12 Suppl):Abstract nr A055. doi:10.1158/1535-7163.
  • Ankita Gupta, Don Mathew, Arnab Pal, Sushmita Ghoshal. Geneticvariants of DNA repair genes as predictors of late radiotoxicity and treatmentoutcome in oropharyngeal carcinoma [abstract]. Cancer Res 2020;80(16 Suppl).

 

NON-INDEXED

  • Sinha A, Pal A*.Biosensors in Medicine: An Overview. NEIGRIHMS Journal of Medical & HealthSciences, 2011; 3: 22-26.

BOOK CHAPTER

  • Hospital Administration:A Problem - Solving Approach, Elsevier, 2014, ISBN-10 8131234606; ClinicalLaboratory Services. Pp 123-126.

*Corresponding Author